Skip to main content
EOVIST 181.43 mg/mL injection, solution by Bayer HealthCare Pharmaceuticals Inc.
EOVIST, 181.43 mg/mL, injection, solution Drug class: Gadolinium-based Contrast Agent. Available on prescription only. Listed by Bayer HealthCare Pharmaceuticals Inc..
Prescription only

EOVIST

Gadoxetate Disodium

Listed by Bayer HealthCare Pharmaceuticals Inc.

Strength
181.43 mg/mL
Form
Injection, Solution
Route
Intravenous
Class
Gadolinium-based Contrast Agent

What it contains

  • Gadoxetate Disodium 181.43 mg/mL

FDA record

Dosage form Injection, Solution
Route Intravenous
Drug class Gadolinium-based Contrast Agent
Approval route NDA — original brand approval
NDC code 50419-320
FDA application NDA022090
Package sizes listed 3
Marketed since July 2008

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.